2CdA is highly active in previously untreated patients with Waldenström's macroglobulinemia. A limited program of treatment induced responses of good quality and long duration in more than 80% of patients.
Meletios A Dimopoulos, Hagop M. Kantarjian, Donna Weber, Susan O’Brien, Elihu H. Estey, Kay Delasalle, Esther Rose, Fernando Cabanillas, Michael M. Keating, Raymond Alexanian
Discussion(0)
No comments yet. Be the first to comment.